RespiVert
High Wycombe
About RespiVert
Respivert is a small molecule drug discovery company for the treatment of chronic obstructive pulmonary diseases, asthma, and cystic fibrosis. The company was incorporated in 2006 and is based in High Wycombe, United Kingdom.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: M&A
- Last round: Series Unknown (Jan 2007)
- Website: respivert.com
- Phone: 44 20 7594 1215
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/respivert-3190821 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.